A Phase 1b, Single-arm, Open-label Clinical Trial to Evaluate Corrected QT Interval and Drug-drug Interaction of Traztuzumab on Carboplatin in the Presence of Docetaxel in Patients With Metastatic Cancer
Phase of Trial: Phase I
Latest Information Update: 12 Dec 2015
At a glance
- Drugs Trastuzumab (Primary) ; Carboplatin; Docetaxel
- Indications Solid tumours
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- Sponsors Genentech
- 07 Jun 2017 Biomarkers information updated
- 07 Oct 2011 Planned end date changed from 1 Feb 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 05 Oct 2011 Planned end date 1 Feb 2013 added as reported by ClinicalTrials.gov.